solid tumor treatment method, activity inhibition method, oral dosage form for treating a solid tumor, solid pharmaceutical formulation, process for preparing a pharmaceutical formulation, and solid pharmaceutical composition
The present invention relates to pharmaceutical compositions comprising (a) human ezh2 histone methyltransferase inhibitor (s) and to methods for cancer therapy using the ezh2 inhibitor (s).a presente invenção se refere a composições farmacêuticas compreendendo (um) inibidor(es) da histona metiltransferase ezh2 humana e a métodos para a terapia do câncer usando o(s) inibidor(es) de ezh2.